RecruitingNot applicable

Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening

Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening (MATCHES)

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
45 Years to 75 Years
Sex
All sexes
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

The MATCHES study tests an education program to help people get screened for both colorectal cancer and hepatitis C. Colorectal cancer affects the colon or rectum, and hepatitis C is a virus that affects the liver. The study is for adults ages 45–75 who get care at participating community health clinics.

This innovative Multilevel Action Toward Colorectal Cancer (CRC) and Hepatitis C Virus (HCV) Education and Screening (MATCHES) intervention aims to promote concurrent HCV and CRC screening among FQHC patients ages 45-75.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • You must be 45–75 and get care at a participating federally qualified health center (FQHC).
  • You must be overdue for colorectal cancer screening, such as having no colonoscopy in the past 10 years or no stool blood test in the past 12 months.
  • You must never have had a hepatitis C antibody screening test and have no symptoms of hepatitis C.
  • You must be able to read, write, and understand English or Spanish and give informed consent, meaning you understand and agree to join.
  • You must have no past colorectal cancer and be at average risk, with no inherited cancer condition or strong family history of this cancer. You must have no signs such as ongoing rectal bleeding, diarrhea, belly pain, or bloating.
  • If you receive study materials, you must be able and willing to complete surveys and take part in the patient education program.
  • If you take part in an interview, you must agree to do it by phone or video call and have your voice recorded.
  • If you join only for an interview and did not receive MATCHES materials, you must have had a clinic visit within the past two months.

Who can't join

  • You cannot join if you do not meet all the requirements that apply to you.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Participants must be receiving care at one of the participating FQHC clinics. * Participants must be 45-75 years of age. * Participants must not be up to date with Colorectal Cancer (CRC) screening recommendations such as no colonoscopy in the past 10 years, occult blood test in the past 12 months. * Participants must never have had Hepatitis C Virus (HCV) antibody screening. * Participants must be able to read, write, and understand English or Spanish. * Participants must have no personal history of CRC or current presumptive CRC symptoms such as unresolved rectal bleeding or abdominal pain/bloating. * Participants must be at average risk for CRC (no hereditary CRC syndromes such as lower gastrointestinal (GI) bleeding, persistent diarrhea, bloating, or lower GI pain, no strong family history of CRC). * Participants must be asymptomatic for HCV. * Participants receiving intervention materials must be able and willing to complete surveys and receive the patient level intervention. * Participants completing qualitative interviews must be willing to complete a remote interview via phone or teleconference software such as ZOOM. * Participants completing qualitative interviews must be willing to be audio recorded. * Participants recruited for qualitative interviews only (did not receive MATCHES intervention materials) must have a clinic visit within prior two months. * All Participants must be able to provide informed consent. Exclusion Criteria: * Participants that do not meet all Inclusion Eligibility requirements will be excluded.

Study sites (1)

FL